Nanobac - dreht vorsichtig nach oben - 500 Beiträge pro Seite

[Corner]

Hallo zusammen !

Hat jemand eine Meinung zu dem Wert NNBP ?

Die Aktie hat sich seit ein paar Wochen bei gut 7 Cent - was gleichzeitig das Tief ist - gehalten und steigt nun
bei noch kleinen Umsätzen - aktuell 8 Cent.

52 Week Range 0,07 - 0,32

www.nanobaclabs.com


Bin leider kein Mediziner um den Erfolg dieser Nanomedizin einschätzen zu können.

NNBP wird unter WKN 912641 auch in Frankfurt und Berlin gehandelt - bisher allerdings kaum Umsatz.

Vielleicht ändert sich das ja bald

Grüße

Corner

[Dersisco]

Auf dem Niveau kann man nicht mehr viel falsch machen.Sollte aus der Kooperation mit der NASA was zählbares rauskommen sind wir schnell bei 1 US$.

Gruß

[Corner]

Hallo zusammen !

Jetzt sind wir bei knapp 9 Cent mit steigenden Umsätzen.

Gut, dass sind gerade mal 15-20% Plus, seit Erwähnung und keine 10.000 %

Ob der 1 USD bald kommt ?

Gruesse

Corner

[Dersisco]

[posting]17.250.941 von Corner am 15.07.05 21:07:15[/posting]Ruhig Brauner.Wird schon.Fängt immer langsam an,bis alle aufspringen.Rechne ab 0,20US$ mit massivem Push Richtung 0,60.Nur dort müssen wir hinkommen.Die kommen von 5 US$.Also,locker bleiben und genießen

[Dersisco]

[posting]17.253.646 von Dersisco am 16.07.05 12:40:32[/posting]OTCBB NNBP USD 0,076 0,095 + 0,019 + 25,00 % 11.461 130.525 19. Jul 21:09
Et läuft.Dröpche für Dröpche!Echte qualität

[lifa]

Antwort auf Beitrag Nr.: 17.278.474 von Dersisco am 19.07.05 21:32:23

[FlopBOB]

Inflammatory Nanoparticles Discovered In Joint Fluid Of Arthritis Patients, Based On Methods Pioneered by Nanobac Pharmaceuticals' Scientists
WEDNESDAY, MAY 03, 2006 11:50 AM
- BusinessWire

TAMPA, Fla., May 03, 2006 (BUSINESS WIRE) -- Nanobac Pharmaceuticals, Inc. (NNBP) ("Nanobac" or "the Company") today announced that Inflammatory nanoparticles that produce calcified deposits like those found in arthritic joints have been cultured from the synovial fluid of rheumatoid arthritis and osteoarthritis patients by Japanese researchers, as reported in the Journal of Proteome Research.

"This is the first report to indicate that human synovial fluids contain Nanobacteria-like particles," the study notes.

The study, Nanobacteria-Like Particles in Human Arthritic Synovial Fluids, by T. Tsurumoto, T. Matsumoto, A. Yonekura, and H. Shindo, Department of Orthopaedics, Graduate School of Biomedical Sciences, Nagasaki University, supports the existence and pathogenic role of nanobacteria-like particles found in human diseases such as heart, prostate and kidney disease by Mayo Clinic and other researchers.

In a two year experiment, calcifying nanoparticles were cultured from the joint fluid of each participating patient, demonstrating that 100 percent of patients had the particles.

The experiment was based on methods pioneered by Nanobac Scientists, Drs. Neva Ciftcioglu and Olavi Kajander.

"After about 2 months of culture, nanoparticles appeared in the synovial fluids from all the patients to greater or lesser degrees," the study found. "These nanoparticles gradually increased in number and in size."

Medical researchers have often theorized about the presence of a calcifying agent that generates associated painful inflammation in arthritis, but until now had never found one.

Nanobacteria produce a calcium phosphate material known as calcification, which is shown in many studies, and cited in the Merck Manual of Diagnosis and Therapy, as provoking inflammation.

"If self-proliferating nanoparticles exist in mammalian synovial fluids and membranes, then they may have an effect on many joint diseases," the study's authors concluded.

"This is another example of independent researchers finding nanobacteria in patients with a specific disease condition," said Nanobac Co-Chairman Dr. Benedict Maniscalco, Fellow of the American College of Cardiology (FACC).

"It shows the value of our research, which is the only work to explain how calcification occurs in diseases afflicting most of the aging population," Dr. Maniscalco added.

The findings come on the heels of a paper published in the World Journal of Urology by Cleveland Clinic researcher Dr. Daniel Shoskes and Dr. Hadley M. Wood, which concluded that nanobacteria-like particles may play a ubiquitous role in prostate disease.

Another independent paper published earlier this year in the journal Urology Research by Khullar et al reports induction of renal calcification by nanobacteria.

Disclosure statement: Nanobac Pharmaceuticals did not fund the arthritis or Khullar studies, so the findings are independent.

Link to study abstract at: http://www.nanobac.com/content/scientific-publications.htm

Quelle: http://bigcharts.marketwatch.com/news/articles.asp?guid={78C…

[lifa]

350% Spread

Frankfurt - 100.000 0,02 0,09 20.000 350,00% 08:26

[Dersisco]

[lifa]

Antwort auf Beitrag Nr.: 21.429.620 von Dersisco am 04.05.06 14:28:34

0,075 $
In Frankfurt dümpeln wir bei 2Cents Da würd ich auch gerne nochmal kaufen !

Nun denn, Thread gelesen heute 4, wenn da mal 400 steht, haben wir die 20 Cent Marke sicher längst hinter uns gelassen...

[lifa]

Nanobac Pharmaceuticals Inc. Announces Investor Conference Call, Hosted by John Stanton, Chairman
Wednesday June 7, 11:49 am ET

TAMPA, Fla.--(BUSINESS WIRE)--June 7, 2006--Nanobac Pharmaceuticals Inc. (OTCBB:NNBP - News) announces it will host an investor conference call on Wednesday, June 14, 2006, to begin at 4:15 P.M. Eastern Time.
In discussing the conference call, John Stanton, Chairman of Nanobac Pharmaceuticals Inc., stated, "We have a commitment to our shareholders as well as the investment community for high level disclosure and communication, and for that reason we are looking forward to discussing our progress and developments with our shareholders and the investment community. We look forward to updating interested parties on recent developments."


http://biz.yahoo.com/bw/060607/20060607005682.html?.v=1

[lifa]

Methods for eradication of nanobacteria
United States Patent 6706290

http://www.patentstorm.us/patents/6706290.html